论文信息 - The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab. - 字舞流文

The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab.

C. Díaz-Torné | J. D. de Agustín | R. Sanmartí | E. Cantó | M. A. Ortiz | S. Vidal | C. Zamora | P. Moya | I. Castellví | H. Corominas | D. Reina | M. V. Hernandez | D. D. L. Fuente | María V. Hernandez